Journal
HUMAN MUTATION
Volume 37, Issue 5, Pages 457-464Publisher
WILEY-BLACKWELL
DOI: 10.1002/humu.22969
Keywords
exon deletion; duplication; targeted next-generation sequencing; NGS; CNV; clinical diagnostics
Categories
Funding
- Netherlands CardioVascular Research Initiative [CVON2011-19]
Ask authors/readers for more resources
We have developed a tool for detecting single exon copy-number variations (CNVs) in targeted next-generation sequencing data: CoNVaDING (Copy Number Variation Detection In Next-generation sequencing Gene panels). CoNVaDING includes a stringent quality control (QC) metric, that excludes or flags low-quality exons. Since this QC shows exactly which exons can be reliably analyzed and which exons are in need of an alternative analysis method, CoNVaDING is not only useful for CNV detection in a research setting, but also in clinical diagnostics. During the validation phase, CoNVaDING detected all known CNVs in high-quality targets in 320 samples analyzed, giving 100% sensitivity and 99.998% specificity for 308,574 exons. CoNVaDING outperforms existing tools by exhibiting a higher sensitivity and specificity and by precisely identifying low-quality samples and regions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available